AzTrials
AzTrials

Breast CancerPhase 2NCT07162298

Dragon Boat Race Versus Family Unsupervised Training to Improve the Physical Function and Quality of Life in Breast Cancer Patients

A Phase 2 study testing Dragon Boat Training and Home-based Unsupervised Training in people with Breast Cancer, run by First Affiliated Hospital of Zhejiang University at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Investigators plans to conduct a randomized, open, single center clinical study of Dragon Boat Race versus family unsupervised training to improve the physical function and quality of life in breast cancer patients to compare the effects of organized and supervised short-term dragon boat training versus unsupervised… Read more about this study

Who is it for?
Ages 18 to 75 years, women only
Conditions the study is for
Breast Cancer
What is being tested?
Dragon Boat Training and Home-based Unsupervised Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 siteChina
Study dates
7 Apr 2025to 7 Apr 2028
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Female patients aged 18-75 years;
  • ECOG performance status of 0-1;
  • BMI between 18.0 and 30.0;
  • No prior experience with dragon boat or kayaking;
  • Histologically or pathologically confirmed invasive breast cancer;
  • Function levels of major organs must meet the following requirements (no blood transfusion, no use of leukocyte-elevating or platelet-elevating drugs within 2 weeks before screening):
Show all 11Show fewer
  • Routine blood test: absolute neutrophil count (ANC) > 1.5×10⁹/L; platelet count (PLT) > 75×10⁹/L; hemoglobin (Hb) > 90g/L; lymphocyte count ≥ 1.5×10⁹/L.
  • Blood biochemistry: total bilirubin (TBIL) < 1.5×ULN; alanine aminotransferase (ALT) and aspartate aminotransferase (AST) < 1.5×ULN; alkaline phosphatase < 2.5×ULN; blood urea nitrogen/urea (BUN/UREA) and creatinine (Cr) < 1.5×ULN.
  • Echocardiography: left ventricular ejection fraction (LVEF) > 55%.
  • 12-lead electrocardiogram: Fridericia-corrected QT interval (QTcF) < 470 msec. For premenopausal female patients or those not surgically sterilized: effective contraceptive methods must be used during treatment and for at least 6 months after the last dose in the study treatment.
  • Voluntary participation in the study, signing of informed consent, good compliance, and willingness to cooperate with follow-up.

Who cannot join

  • Stage IV breast cancer.
  • Inflammatory breast cancer.
  • Previous receipt of anti-tumor therapy or radiotherapy for any malignant tumor, excluding cured malignant tumors such as carcinoma in situ of the cervix, basal cell carcinoma, or squamous cell carcinoma.
  • Concurrent receipt of anti-tumor therapy in other clinical trials, including but not limited to chemotherapy, endocrine therapy, biological therapy, bone-modifying agent therapy, or immune checkpoint inhibitor therapy.
  • Previous regular participation in physical activity (moderate to vigorous exercise at least twice a week).
  • Severe heart disease or discomfort, including but not limited to the following conditions:
Show all 18Show fewer
  • Confirmed history of heart failure or systolic dysfunction (LVEF less than 50%).
  • High-risk uncontrolled arrhythmias, such as atrial tachycardia, resting heart rate greater than 100 bpm, significant ventricular arrhythmias (e.g., ventricular tachycardia), or higher-grade atrioventricular block (i.e., Mobitz II second-degree atrioventricular block or third-degree atrioventricular block).
  • Angina pectoris requiring anti-anginal medication.
  • Clinically significant valvular heart disease.
  • ECG showing transmural myocardial infarction.
  • Poorly controlled hypertension (systolic blood pressure greater than 180 mmHg and/or diastolic blood pressure greater than 100 mmHg after drug treatment).
  • Uncontrolled active infection requiring treatment; history of immunodeficiency, including positive HIV test, or other acquired or congenital immunodeficiency diseases, or history of organ transplantation.
  • Patients with active chronic hepatitis B or active hepatitis C (excluding hepatitis B virus carriers, hepatitis B patients stable after drug treatment [HBV-DNA test negative or < 50 IU/ml], and cured hepatitis C patients [HCV RNA test negative]).
  • Patients with any other chronic diseases (such as hypertension, diabetes, coronary heart disease, COPD, etc.).
  • Patients unable to tolerate moderate to vigorous exercise.
  • Pregnant or lactating female patients, female patients with childbearing potential and positive baseline pregnancy test, or women of childbearing age who are unwilling to take effective contraceptive measures throughout the trial and within 6 months after the last study medication.
  • Patients with severe concomitant diseases or other comorbidities that would interfere with the planned treatment, or any other conditions deemed by the researcher to make the patient unsuitable for participation in the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Zhijun Dai Professor contact

+86 157 0581 9132

dzj0911@126.com

China1 site, 1 recruiting
  • The First Affiliated Hospital of Zhejiang University

    Hangzhou

    Zhijun Dai, Professor, +86 157 0581 9132, dzj0911@126.com

    Youyi Chen Chen, 913589289@qq.com

    Recruiting

Other trials in China

About this study

Official title: A Randomized, Open, Single Center Clinical Study of Dragon Boat Race Versus Family Unsupervised Training to Improve the Physical Function and Quality of Life in Breast Cancer Patients

Investigators plans to conduct a randomized, open, single center clinical study of Dragon Boat Race versus family unsupervised training to improve the physical function and quality of life in breast cancer patients to compare the effects of organized and supervised short-term dragon boat training versus unsupervised home training on body composition, physical function, and quality of life in women after breast cancer surgery. Participants will be assigned to the following intervention protocols at a 1:1 ratio:Dragon Boat Training Group (DB): Conduct 12-week dragon boat training under the guidance of professional coaches.Home-based Unsupervised Training Group (HG): Perform exercises at home independently according to instructional videos for 12 weeks.The primary outcomes are to analyze differences in body composition, physical function, and quality of life.The secondary exploratory outcomes include stratified factors such as menopausal status and surgical methods

Conditions
Breast Cancer
Being tested
Dragon Boat Training, Home-based Unsupervised Training
Keywords
Breast cancer, Post-operation, Dragon Boat Race, Physical function, Quality of life
Medical subject headings
Breast Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dragon Boat TrainingOther

    The total training duration is 12 weeks, divided into cycles of 4 weeks each, with distinct training contents and goals for every cycle. Training sessions are held 3 times a week, and all participants train together on the same day. Each training session lasts approximately 60 minutes.

    In the first 4 weeks, participants spend half an hour training on land and the subsequent half an hour training on dragon boats.

    Then, from week 4 to week 8, they train for 20 minutes on land and 40 minutes on dragon boats.

    Finally, from week 8 to week 12, they only conduct 10-15 minutes of land training (as warm-up) followed by nearly an hour of on-boat training.

    This progressive training plan is designed to ensure that each participant can tolerate the training intensity as much as possible, preventing injuries caused by training.

  • Home-based Unsupervised TrainingOther

    The total training duration is 12 weeks. After a 15-minute warm-up (including walking, exercises, etc.), participants will perform the following 10 movements in sequence: squats, rowing simulation with rubber bands, lateral raises, sit-ups, shoulder presses, alternating bilateral lunges, dumbbell curls (for biceps), sit-ups, and planks.

    Each movement lasts 60 seconds, with a 10-second rest allowed midway through the same movement (i.e., 15 seconds of exercise followed by a 10-second rest, then another 15 seconds to complete the movement). A 20-second rest is permitted before moving on to the next movement.

    Once participants can complete 30 seconds of the same movement without needing rest or adjustment, the training intensity will be increased-progressing from one round of training (10 minutes) to two rounds (20 minutes) or even three rounds (30 minutes).

Study groups in NCT07162298
Study groupRoleWhat they receive
Dragon Boat Training Group (DB)ExperimentalThe total training duration is 12 weeks, divided into cycles of 4 weeks each, with distinct training contents and goals for every cycle. Training sessions are held 3 times a week, and all participants train together on the same day. Each training session lasts approximately 60 minutes. In the first 4 weeks, participants spend half an hour training on land and the subsequent half an hour training on dragon boats. Then, from week 4 to week 8, they train for 20 minutes on land and 40 minutes on dragon boats. Finally, from week 8 to week 12, they only conduct 10-15 minutes of land training (as warm-up) followed by nearly an hour of on-boat training. This progressive training plan is designed to ensure that each participant can tolerate the training intensity as much as possible, preventing injuries caused by training.
Receives: Other: Dragon Boat Training
Home-based Unsupervised Training Group (HG)Active comparatorThe total training duration is 12 weeks. After a 15-minute warm-up (including walking, exercises, etc.), participants will perform the following 10 movements in sequence: squats, rowing simulation with rubber bands, lateral raises, sit-ups, shoulder presses, alternating bilateral lunges, dumbbell curls (for biceps), sit-ups, and planks. Each movement lasts 60 seconds, with a 10-second rest allowed midway through the same movement (i.e., 15 seconds of exercise followed by a 10-second rest, then another 15 seconds to complete the movement). A 20-second rest is permitted before moving on to the next movement. Once participants can complete 30 seconds of the same movement without needing rest or adjustment, the training intensity will be increased-progressing from one round of training (10 minutes) to two rounds (20 minutes) or even three rounds (30 minutes).
Receives: Other: Home-based Unsupervised Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. BMI (kg/m²)

    BMI (kg/m²) weight and height will be combined to report BMI in kg/m^2

    Measured: 1 year

Secondary outcomes (2)
  1. Physical function

    Six-minute walk test (6MWT, m):The test is conducted in an indoor, long, straight, and flat rectangular area with a 30-meter walking route, where participants walk back and forth repeatedly. They should walk at their usual pace and rhythm as much as possible, without the need for brisk walking or jogging. The distance walked by the participants after 6 minutes is recorded. The formula reported by Enright and Sherrill, which is based on body mass index (BMI) and age, is used to compare with the 6-minute walk distance (6MWD) of normal healthy populations (for males: 6MWD (m) = 1140m - 5.61 × BMI (kg/m²) - 6.94 × age (years); for females: 6MWD (m) = 1017m - 6.24 × BMI (kg/m²) - 5.83 × age (years)).

    Measured: 1 year

  2. Psychological status

    Self-report measurement method used to assess people's acceptance of their own bodies, respect and care for their bodies, and protection of their bodies from unrealistic beauty standards. All items are rated on a 5-point scale (1 = never, 5 = always), and the total score is calculated as the average of all items, so a higher score reflects a higher level of body appreciation.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Sep 2025
  2. Study start7 Apr 2025
  3. Primary completion7 Apr 2026 (estimated)
  4. Study completion7 Apr 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
72 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07162298
Sponsor's protocol ID
IIT20250005C
Status last verified
Jul 2025
First submitted
22 Jul 2025
Last updated
9 Sep 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Dragon Boat Training and Home-based Unsupervised Training in people with Breast Cancer, run by First Affiliated Hospital of Zhejiang University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 18 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Zhijun Dai Professor (+86 157 0581 9132, dzj0911@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

BMI (kg/m²) (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in